Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Dupuytren's NICE draft guidance

The National Institute for Health and Care Excellence (NICE) has issued draft guidance for consultation that does not recommend collagenase clostridium histolyticum (Xiapex) for the treatment of Dupuytren’s contracture, a condition that causes the fingers of the hands to gradually bend in towards to the palm and cannot be straightened. More information can be found on the NICE website under ID621. The deadline for comments is 28 November 2014.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067131

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.